Here's a look at some of the top Wall Street stories for medical device companies this week: Blockbuster: Medtronic in $43B deal to acquire Covidien; Medtronic buyout holds $80M in golden parachutes for Covidien execs; FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device; European Commission tables review of Zimmer's $13B acquisition of Biomet; Ackman takes Allergan to court to defend against poison pill
Blockbuster: Medtronic in $43B deal to acquire Covidien
June 16, 2014 by Brad Perriello
Zimmer Holdings, Biomet, Boston Scientific, Covidien, European Commission, Food & Drug Administration (FDA), Medtronic, Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/TapWtt
Cap comentari:
Publica un comentari a l'entrada